Xeris Biopharma Holdings, Inc.

NASDAQ:XERS

2.96 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22017 Q3
Assets:
Current Assets:
Cash & Cash Equivalents 57.60462.6967.44946.14346.1750.98446.1750.98495.34103.77167.27159.49263.59966.60437.59837.886102.46539.24419.51956.1666.66961.98445.71675.745134.52858.1142.045-32.269
Short Term Investments 19.96424.6625.00219.83234.49844.11834.49844.11816.21328.37735.16233.49152.38169.2996.19103.85741.5357.69856.0346.31157.84185.68766.91755.29600064.538
Cash and Short Term Investments 77.56887.35272.45165.97580.66895.10280.66895.102111.553132.148102.43392.983115.98135.894133.788141.743143.99596.94275.549102.471124.51147.671112.633131.041134.52858.1142.04532.269
Net Receivables 42.4437.41439.19745.96630.22530.8630.22530.8625.75623.38317.45613.56112.2958.9386.87512.193.8723.2585.6390.8740.8263.6282.8691.7311.0650.2871.1990
Inventory 42.97740.87838.83838.14336.53829.03936.53829.03917.88716.87218.11814.24112.29912.4968.3535.6334.8242.1662.176000000000
Other Current Assets 7.3557.6365.7787.9678.3110.5128.3110.5126.015.1474.5893.5824.0143.2983.1963.663.6723.1544.1192.6310.8132.1462.3972.8981.4391.4380.8090
Total Current Assets 170.34173.28156.264158.051155.741165.513155.741165.513161.206177.55142.596124.367144.588160.626152.212163.226156.363105.5287.483105.976126.149153.445117.899135.67137.03259.83544.05332.269
Non-Current Assets:
Property, Plant & Equipment, Net 28.69728.8129.17529.59230.18410.36330.18410.3636.176.2916.6276.6826.6976.7996.7076.9287.3877.5937.8537.9527.6777.432.0341.8261.1361.0580.7880
Goodwill 22.85922.85922.85922.85922.85922.85922.85922.85922.85922.85922.85900000000000000000
Intangible Assets 104.343107.053109.764112.475115.186117.896115.186117.896126.029128.739131.4500000000000000000
Goodwill and Intangible Assets 127.202129.912132.623135.334138.045140.755138.045140.755148.888151.598154.30900000000000000000
Long Term Investments 4.2254.2254.225004.3484.348000-0.364000001.792.99213.23113.91300000000
Tax Assets 0-018.19600-4.3480.1150000.36400000000000000000
Other Non-Current Assets 1.2690.3890.3154.8074.8084.7290.3454.7292.3522.1840.4650.2110.2110.2120.2320.3050.270.3570.420.2590.0680.0950.0950.0950.0880.6710.157-32.269
Total Non-Current Assets 161.393163.336184.534169.733173.037155.847173.037155.847157.41160.073161.7656.8936.9087.0116.9397.2339.44710.94221.50422.1247.7457.5252.1291.9211.2241.7290.945-32.269
Total Assets 331.733336.616340.798327.784328.778321.36328.778321.36318.616337.623304.361131.26151.496167.637159.151170.459165.81116.462108.987128.1133.894160.97120.028137.591138.25661.56444.9980
Liabilities & Equity:
Current Liabilities:
Account Payables 5.7987.09411.56512.07811.62111.98311.62111.9836.63111.0918.9244.295.1854.7683.1174.6944.443.845.6031.6781.841.4080.8660.6220.5560.8471.9760
Short Term Debt 5.3074.6243.4952.3661.9351.4481.9351.44800.34100000000015.706311.4828.2146.267.5427.5592.5570
Tax Payables 0000000000000000000000000000
Deferred Revenue 00053.95547.76750.27747.7670000000000000.1060.1560.2210.2320.2840.2840.2840.2340
Other Current Liabilities 64.38361.36680.13318.6418.35517.71518.35567.99257.91455.0670.11632.99530.27922.65625.0922.48118.34718.0421.7350.30216.0120.2950.861.0420.8070.5010.0930
Total Current Liabilities 75.48873.08495.19387.03979.67881.42379.67881.42364.54566.49279.0437.28535.46427.42428.20727.17522.78721.8827.33817.79221.00813.40610.1728.2089.1899.1914.860
Non-Current Liabilities:
Long Term Debt 230.481229.674190.932225.577223.053196.969223.053196.969138.068137.63988.06787.71387.47887.27287.021119.391109.47658.48558.30558.12429.40332.14131.8931.64218.16718.05100
Deferred Revenue Non-Current 34.01634.39734.76400000006.88300000000000000000
Deferred Tax Liabilities Non-Current 3.3242.57520.4642.5042.8433.5182.8433.5184.1954.5344.94200000000000000000
Other Non-Current Liabilities 7.716.0646.2278.7999.5639.4029.5639.40237.86532.50330.1988.7238.6668.55410.1629.6329.1669.0288.9088.5288.6928.3232.562.6211.5631.47297.9680
Total Non-Current Liabilities 275.531272.71252.387236.88235.459209.889235.459209.889180.128174.676130.0996.43696.14495.82697.183129.023118.64267.51367.21366.65238.09540.46434.4534.26319.7319.52397.9680
Total Liabilities 351.019345.794347.58323.919315.137291.312315.137291.312244.673241.168209.13133.721131.608123.25125.39156.198141.42989.39394.55184.44459.10353.8744.62242.47128.91928.714102.8280
Equity:
Preferred Stock 000603.67100591.51000000000000000000102.29297.87862.898
Common Stock 0.0150.0150.0140.0140.0140.0140.0140.0140.0140.0140.0130.0070.0070.0070.0060.0050.0050.0040.0030.0030.0030.0030.0020.0020.0020.0010.0010
Retained Earnings -651.01-636.005-617.025-603.635-591.446-571.604-591.446-571.604-520.009-493.824-460.11-409.32-383.311-355.796-337.385-315.528-299.528-275.429-246.245-213.163-180.327-145.942-120.665-100.246-85.478-72.492-60.5850
Accumulated Other Comprehensive Income/Loss -0.031-0.036-0.025-0.05-0.078-0.029-0.078-0.029-0.052-0.066-0.031-0.026-0.02-0.010.0060.0560.1640.060.0430.0450.068-0.001-0.052-0.0580-102.292-0.44-31.934
Other Total Stockholders Equity 631.74626.848610.2543.865605.151601.66713.641601.667593.99590.331555.359406.878403.212400.186371.134329.728323.74302.434260.635256.771255.047253.04196.121195.422194.8133.049-94.6840
Total Shareholders Equity -19.286-9.178-6.7823.86513.64130.04813.64130.04873.94396.45595.231-2.46119.88844.38733.76114.26124.38127.06914.43643.65674.791107.175.40695.12109.33732.85-57.8330.964
Total Equity -19.286-9.178-6.7823.86513.64130.04813.64130.04873.94396.45595.231-2.46119.88844.38733.76114.26124.38127.06914.43643.65674.791107.175.40695.12109.33732.85-57.8330.964
Total Liabilities & Shareholders Equity 331.733336.616340.798327.784328.778321.36328.778321.36318.616337.623304.361131.26151.496167.637159.151170.459165.81116.462108.987128.1133.894160.97120.028137.591138.25661.56444.99830.964